SIRT1 and neoplasm: Therefore, the SIRT1 distributional patterns in all patient samples and the adjacent tumours were analysed: only 1 of 33 osteosarcoma cases (3%) demonstrated no SIRT1 expression in tumour tissues, whereas 29 samples (87.9%) showed intense SIRT1 immunoreactivity.